Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ifebemtinib (IN10018)
i
Other names:
N-10018, IN 10018, N 10018, BI853520, IN-10018, IN10018, BI-853520, N10018, BI 853520
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Boehringer Ingelheim, InxMed
Drug class:
FAK inhibitor
Related drugs:
‹
VS-6063 (8)
LY294002 (7)
AZD0530 (7)
VS-4718 (5)
APG-2449 (4)
GSK2256098 (1)
PF-562271 (1)
SY-707 (1)
CEP-37440 (0)
FAK-JAK 2 dual Inhib (0)
NVP-TAE226 (0)
PF-573228 (0)
VS-6063 (8)
LY294002 (7)
AZD0530 (7)
VS-4718 (5)
APG-2449 (4)
GSK2256098 (1)
PF-562271 (1)
SY-707 (1)
CEP-37440 (0)
FAK-JAK 2 dual Inhib (0)
NVP-TAE226 (0)
PF-573228 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Ovarian Cancer
No biomarker
Ovarian Cancer
IN10018
Sensitive: B - Late Trials
IN10018
Sensitive
:
B
IN10018
Sensitive: B - Late Trials
IN10018
Sensitive
:
B
KRAS G12C
Solid Tumor
KRAS G12C
Solid Tumor
MRTX1257 + IN10018
Sensitive: C3 – Early Trials
MRTX1257 + IN10018
Sensitive
:
C3
MRTX1257 + IN10018
Sensitive: C3 – Early Trials
MRTX1257 + IN10018
Sensitive
:
C3
KRAS G12C
Solid Tumor
KRAS G12C
Solid Tumor
sotorasib + IN10018
Sensitive: D – Preclinical
sotorasib + IN10018
Sensitive
:
D
sotorasib + IN10018
Sensitive: D – Preclinical
sotorasib + IN10018
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login